BACKGROUND: HTLV-II is a human retrovirus considered to be responsible
for the genesis of some lymphoproliferative and neurologic syndromes.
The virus is endemic in some Amerindian and African tribes as well as
amongts injecting drug addicts (IDA) in North America and Europe. MET
HODS: The clinical, epidemiologic and virologic characteristics of the
patients with HTLV-II infection identified in Spain up to November 19
94 are described. RESULTS: One hundred thirteen subjects have been ide
ntified with HTLV-II infection in Spain with 4 being African immigrant
s residing in Madrid and the remaining being IDA from other European c
ountries. Most were males (94/113; 83%). Art were IDA except six (5 ha
d acquired the infection by sexual contact and one by blood transfusio
n). Most of the IDA infected with HTLV-II were coinfected with HIV-I (
93/113; 83%). No patient showed clinical manifestations attributable t
o HTLV-II infection although one drug addict male coinfected with HIV-
1 and HTLV-II developed a non-inflammatory proximal myopathy. CONCLUSI
ONS: Infection by HTLV-II is present in Spain and affects with prefere
nce to injecting drug addicts, It has been shown to be of growing inci
dence with a current global prevalence of 2% in IDA.